UBS O'Connor’s Moringa Acquisition Corp Warrant MACAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-102,757
Closed -$56K 305
2021
Q4
$56K Buy
102,757
+2,757
+3% +$1.64K ﹤0.01% 900
2021
Q3
$61K Hold
100,000
﹤0.01% 872
2021
Q2
$79K Buy
+100,000
New +$63.5K ﹤0.01% 847

Other funds holding MACAW

UBS O'Connor's MACAW Position: Q1 2022 in Review

UBS O'Connor sold out of Moringa Acquisition Corp Warrant (MACAW) in Q1 2022, closing a stake of 102,757 shares — an estimated $56K sold.

UBS O'Connor first reported a position in MACAW in Q2 2021 and held it in 3 quarters. The position peaked at $79K in Q2 2021. 32 funds tracked by Wall St. Rank hold MACAW as of Q1 2022.

  • UBS O'Connor reported no remaining Moringa Acquisition Corp Warrant position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 102,757 Moringa Acquisition Corp Warrant shares in Q1 2022, an estimated $56K.
  • UBS O'Connor first reported a position in Moringa Acquisition Corp Warrant in Q2 2021 and held it in 3 quarters.
  • UBS O'Connor's Moringa Acquisition Corp Warrant position peaked at $79K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Moringa Acquisition Corp Warrant as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.